Search research articles
Contact Us
Filters
Showing results (51-60 of 277) with videos related to
Page
of 28
Sort By:
Deutsches Arzteblatt International
|
August 24, 2021
Imaging of Prostate Cancer
Heinz-Peter Schlemmer, Bernd Joachim Krause, Viktoria Schütz, et al.
BJU International
|
December 17, 2008
Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences
Jens Bedke, Stephan Buse, Maria Pritsch, et al.
BJU International
|
April 7, 2010
Risk factors and clinical management of haemorrhage after open nephron-sparing surgery
Johannes Huber, Sascha Pahernik, Peter Hallscheidt, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
November 23, 2017
APOBEC3A Expression in Penile Squamous Cell Carcinoma
Martina Heller, Elena-Sophie Prigge, Adam Kaczorowski, et al.
Cancer Treatment and Research Communications
|
November 3, 2020
Detection of AR-V7 in primary prostate cancer
Adam Kaczorowski, Xin Chen, Glen Kristiansen, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS
|
April 5, 2012
Pitfalls of electromagnetic tracking in clinical routine using multiple or adjacent sensors
Ingmar Wegner, Dogu Teber, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 13, 2018
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>225</sup>Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, et al.
Journal of Endourology
|
August 18, 2016
Intraoperative Computed Tomography Imaging for Navigated Laparoscopic Renal Surgery: First Clinical Experience
Tobias Simpfendörfer, Claudia Gasch, Gencay Hatiboglu, et al.
Urologic Oncology
|
July 6, 2014
The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal-Implications for targeted therapies
Meike Schneider, Nina Korzeniewski, Konstanze Merkle, et al.
Anticancer Research
|
February 11, 2014
Does a venous tumor thrombus exclude renal transitional cell carcinoma? Implications for neo-adjuvant treatment strategies
Johannes Huber, Dogu Teber, Gencay Hatiboglu, et al.
Page
of 28
Search research articles
Search
Showing results (51-60 of 277) with videos related to
Sort By:
Page
of 28
Deutsches Arzteblatt International
|
August 24, 2021
Imaging of Prostate Cancer
Heinz-Peter Schlemmer, Bernd Joachim Krause, Viktoria Schütz, et al.
BJU International
|
December 17, 2008
Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences
Jens Bedke, Stephan Buse, Maria Pritsch, et al.
BJU International
|
April 7, 2010
Risk factors and clinical management of haemorrhage after open nephron-sparing surgery
Johannes Huber, Sascha Pahernik, Peter Hallscheidt, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
November 23, 2017
APOBEC3A Expression in Penile Squamous Cell Carcinoma
Martina Heller, Elena-Sophie Prigge, Adam Kaczorowski, et al.
Cancer Treatment and Research Communications
|
November 3, 2020
Detection of AR-V7 in primary prostate cancer
Adam Kaczorowski, Xin Chen, Glen Kristiansen, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS
|
April 5, 2012
Pitfalls of electromagnetic tracking in clinical routine using multiple or adjacent sensors
Ingmar Wegner, Dogu Teber, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 13, 2018
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>225</sup>Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, et al.
Journal of Endourology
|
August 18, 2016
Intraoperative Computed Tomography Imaging for Navigated Laparoscopic Renal Surgery: First Clinical Experience
Tobias Simpfendörfer, Claudia Gasch, Gencay Hatiboglu, et al.
Urologic Oncology
|
July 6, 2014
The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal-Implications for targeted therapies
Meike Schneider, Nina Korzeniewski, Konstanze Merkle, et al.
Anticancer Research
|
February 11, 2014
Does a venous tumor thrombus exclude renal transitional cell carcinoma? Implications for neo-adjuvant treatment strategies
Johannes Huber, Dogu Teber, Gencay Hatiboglu, et al.
Page
of 28